![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/03/FNDR-20123-is-an-Orally-Active-and-a-First-in-Class-Anti-Malarial-HDAC-Inhibitor-2021-03-20.jpg)
Malaria remains one of the most severe and life-threatening infectious diseases. Among the various Plasmodium spp., Plasmodium falciparum is the most…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/10/SJ000025081-a-Dihydropyridine-Acts-as-a-Potent-Antimalarial-Agent-2020-10-17.jpg)
Malaria is a mosquito-borne infectious disease that affects humans and other animals. Specifically, malaria caused Symptoms usually including fever, fatigue,…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/06/AN3661-an-Antimalarial-Agent-is-a-PfCPSF3-Inhibitor-2020-06-09.jpg)
Cleavage and polyadenylation specificity factor (CPSF) is relevant to the cleavage of the 3′ signaling region from a newly synthesized…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/09/TCMDC-135051-a-Highly-Selective-iPfiCLK3-Inhibitor-Has-Potential-to-Treat-Malaria-2019-09-20.jpg)
PfCLK3 is a protein kinase essential for maintaining the asexual blood stage of both P. falciparum and P. berghei. In mammalian cells, the…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/07/CWHM-1552-is-an-Orally-Acitive-Antimalarial-Compound-2019-07-25.jpg)
Malaria has been a military problem throughout history capable of causing epidemics that stop military operations. Particularly, malaria has had…